Immune Checkpoint Blockade in Hepatocellular Carcinoma: Current Progress and Future Directions

被引：190
|
作者：
Hato, Tai [1 ]
Goyal, Lipika [2 ]
Greten, Tim F. [3 ]
Duda, Dan G. [1 ]
Zhu, Andrew X. [2 ]
机构：
[1] Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Lab, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Ctr Canc, Dept Med, Boston, MA 02114 USA
[3] NCI, Gastrointestinal Malignancy Sect, Thorac & Gastrointestinal Oncol Branch, Bethesda, MD 20892 USA
来源：
HEPATOLOGY | 2014年 / 60卷 / 05期
基金：
美国国家卫生研究院;
关键词：
REGULATORY T-CELLS; PERCUTANEOUS ETHANOL INJECTION; SUPPRESSOR-CELLS; POSTOPERATIVE RECURRENCE; CTLA-4; BLOCKADE; LIVER; RESPONSES; PD-1; MOLECULES; HEPATITIS;
D O I：
10.1002/hep.27246
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Immune checkpoint blockade has recently emerged as a promising therapeutic approach for various malignancies including hepatocellular carcinoma (HCC). Preclinical and clinical studies have shown the potential benefit of modulating the immunogenicity of HCC. In addition, recent advances in tumor immunology have broadened our understanding of the complex mechanism of immune evasion. In this review we summarize the current knowledge on HCC immunology and discuss the potential of immune checkpoint blockade as a novel HCC therapy from the basic, translational, and clinical perspectives.
引用
收藏
页码：1776 / 1782
页数：7
相关论文
共 50 条
  • [21] Checkpoint blockade in the treatment of breast cancer: current status and future directions
    Wein, Lironne
    Luen, Stephen J.
    Savas, Peter
    Salgado, Roberto
    Loi, Sherene
    BRITISH JOURNAL OF CANCER, 2018, 119 (01) : 4 - 11
  • [22] Immune checkpoint therapy-current perspectives and future directions
    Sharma, Padmanee
    Goswami, Sangeeta
    Raychaudhuri, Deblina
    Siddiqui, Bilal A.
    Singh, Pratishtha
    Nagarajan, Ashwat
    Liu, Jielin
    Subudhi, Sumit K.
    Poon, Candice
    Gant, Kristal L.
    Herbrich, Shelley M.
    Anandhan, Swetha
    Islam, Shajedul
    Amit, Moran
    Anandappa, Gayathri
    Allison, James P.
    CELL, 2023, 186 (08) : 1652 - 1669
  • [23] Progress of immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma
    Liu, Tong
    Meng, Guorui
    Ma, Shihui
    You, Junqi
    Yu, Liang
    He, Risheng
    Zhao, Xudong
    Cui, Yunfu
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [24] Immune checkpoint inhibitors for head and neck squamous cell carcinoma: Current landscape and future directions
    Kao, Hsiang-Fong
    Lou, Pei-Jen
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2019, 41 : 4 - 18
  • [25] Sarcopenia in hepatocellular carcinoma: Current knowledge and future directions
    Perisetti, Abhilash
    Goyal, Hemant
    Yendala, Rachana
    Chandan, Saurabh
    Tharian, Benjamin
    Thandassery, Ragesh Babu
    WORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28 (04) : 432 - 448
  • [26] Hepatocellular carcinoma surveillance: current practice and future directions
    Ahn, Joseph C.
    Lee, Yi-Te
    Agopian, Vatche G.
    Zhu, Yazhen
    You, Sungyong
    Tseng, Hsian-Rong
    Yang, Ju Dong
    HEPATOMA RESEARCH, 2022, 8
  • [27] Management of Hepatocellular Carcinoma: Current Status and Future Directions
    Au, Jennifer S.
    Frenette, Catherine T.
    GUT AND LIVER, 2015, 9 (04) : 437 - 448
  • [28] Immune Checkpoint Blockade Therapy for Hepatocellular Carcinoma: Clinical Challenges and Considerations
    Zhang, Qi
    Chen, Yiwen
    Bai, Xueli
    Liang, Tingbo
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [29] Sarcopenia in hepatocellular carcinoma: Current knowledge and future directions
    Abhilash Perisetti
    Hemant Goyal
    Rachana Yendala
    Saurabh Chandan
    Benjamin Tharian
    Ragesh Babu Thandassery
    World Journal of Gastroenterology, 2022, (04) : 432 - 448
  • [30] Cure the Incurable? Recent Breakthroughs in Immune Checkpoint Blockade for Hepatocellular Carcinoma
    Chu, Pei-Yi
    Chan, Shih-Hsuan
    CANCERS, 2021, 13 (21)
12345